MedTrace Logo

Pentraxin-3 in Hysterectomy Patients

NCT04366375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-04-30

No results posted yet for this study

Summary

Comparison of the Tissue Trauma Markers Following Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy

Conditions

  • Laparoscopic Hysterectomy
  • Abdominal Hysterectomy

Interventions

DIAGNOSTIC_TEST

PTX-3

Pentraxin-3 ng/mL PTX-3 levels were measured using human PTX3 ELISA Kit 96 Tests/Box (Cat. No: CK-E90303) (Hangzhou Eastbiopharm Co.,Ltd., PRC) read by a ELISA device matching with the kit. For the purpose of measurement, microplate washer RT 2600 device and Rayto microplate reader RT 2100C device were used.

Sponsors & Collaborators

  • Muğla Sıtkı Koçman University

    lead OTHER

Principal Investigators

  • Burak SEZGİN, Dr · Mugla Sıtkı Kocman University Faculty of Medicine

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-13
Primary Completion
2015-12-07
Completion
2015-12-07

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04366375 on ClinicalTrials.gov